30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Garry Menzel

Track

Insider profile

Currently holds a position at TCR2 Therapeutics Inc

Performance

Overall performance
3.2
Performance over holding periods
3.2
30 days 90 days 120 days
Average return 7% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
President, Chief Executive Officer, Director TCR2 Therapeutics Inc Dec. 1, 2018 -
Chief Executive Officer, Director TCR2 Therapeutics Inc Jan. 1, 2016 - Dec. 1, 2018
Executive Vice President, Chief Business and Strategy Officer Axcella Health Inc Oct. 1, 2015 - Jan. 1, 2018
Chief Financial Officer DaVita Inc Nov. 1, 2013 - March 30, 2015
Chief Operating Officer, Executive Vice President - Finance Regulus Therapeutics Inc Jan. 2, 2009 - June 21, 2013
Garry Menzel's trades of Adaptimmune Therapeutics PLC's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-07-10 2023-07-10
S Sale
63,609 -43.9%
252.41
US$912,370 		63,609 -43.9% 252.41 US$912,370
2022-12-13 2022-12-13
PlS Planned sale
89,732 -1.0%
498.06
US$561,911 		89,732 -1.0% 498.06 US$561,911
2022-12-13 2022-12-12
PlS Planned sale
25,665 -40.2%
72.90
US$3,936,504 		25,665 -40.2% 72.90 US$3,936,504
2022-12-13 2022-12-09
PlS Planned sale
10,325 -6.0%
1.13
US$11,678 		10,325 -6.0% 1.13 US$11,678
2022-12-09 2022-12-08
PlS Planned sale
9,314 -5.2%
1.25
US$11,680 		9,314 -5.2% 1.25 US$11,680
2022-12-09 2022-12-07
PlS Planned sale
9,111 -4.8%
1.28
US$11,680 		9,111 -4.8% 1.28 US$11,680
2022-12-07 2022-12-06
PlS Planned sale
14,886 -7.3%
1.35
US$20,081 		14,886 -7.3% 1.35 US$20,081
2022-12-07 2022-12-05
PlS Planned sale
8,530 -4.0%
1.37
US$11,703 		8,530 -4.0% 1.37 US$11,703
2022-12-05 2022-12-02
PlS Planned sale
8,408 -3.8%
1.39
US$11,687 		8,408 -3.8% 1.39 US$11,687